Clopidogrel vs aspirin after staph bloodstream infection
Treatments studied
Part of Blood & lymphatic, Heart & circulation, Infections clinical trials.
This trial compares two blood-thinning medicines, clopidogrel and aspirin, to see which better prevents heart attacks and strokes in people who have had a staph infection in their blood. If you already take aspirin for heart or blood vessel problems, this study may help find the safest way to protect your heart.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are already taking aspirin to prevent heart attacks, strokes, or other heart or blood vessel problems.
- You have had a staph (S. aureus) bloodstream infection.
- You are not currently bleeding and do not have a recent serious bleed.
- You are not pregnant or breastfeeding.
- You have not taken clopidogrel, prasugrel, or ticagrelor in the last month.
- You are not allergic to clopidogrel and are not taking certain other blood thinners (like Xa inhibitors or dabigatran).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two types of blood thinners (dabigatran vs. a common Xa inhibitor like apixaban) in people with a staph infection in their blood. The goal is to see which is safer and works better.
This trial tests whether adding clopidogrel, a blood thinner, to standard care can help treat staph bloodstream infections. It may reduce the risk of complications, but it is only for patients who can take oral medications and are not at high risk of bleeding.
This trial is testing whether lowering the dose of your current blood thinner or switching to a different one (clopidogrel) is safer and works just as well after you've had a stent placed. It's designed for people who are already on two blood thinners and are doing well.
This trial compares two blood-thinning medicines—clopidogrel and aspirin—after you have finished a short period of dual therapy following a special type of drug-eluting heart stent. It may help find which medicine works better and is safer for preventing future heart problems.
This trial studies ways to reduce bleeding in people after a stent procedure (PCI) who have been taking two anti-platelet medicines (aspirin plus prasugrel or ticagrelor) for a set amount of time. It may help find a safer plan for preventing blood clots while lowering bleeding risk.
This study compares two common blood-thinner combinations to see which one works better at preventing clots during stent placement for an unruptured brain aneurysm. It is designed for people whose bodies process these medications normally, with the goal of finding the safest and most effective option.
Hear when a new Staphylococcus Aureus Endocarditis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.